Skip to main content
SpringerLink
Log in

Use ACE inhibitors for persistent microalbuminuria in diabetes

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weidmann P, Schneider M, Bohlen L. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Transplant 1995; 10 Suppl. 9: 39–45

    Google Scholar 

  2. Cooper ME, Vranes D, Rumble JR. Diabetic vascular injury and ACE; potential for pharmacological prevention of complications of later life. Drug Aging 1996; 8(1): 38–6

    Article  CAS  Google Scholar 

  3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86

    Article  Google Scholar 

  4. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–62

    Article  PubMed  CAS  Google Scholar 

  5. Captopril and the kidney. Prescrire International 1996; 5: 18–9

    Google Scholar 

  6. Foote EF. Prevention and treatment of diabetic nephropathy. Am J Health Sys Pharm 1995; 52: 1781–92

    CAS  Google Scholar 

  7. Marre M, Chatellier G, Leblanc H, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297: 1092–5

    Article  PubMed  CAS  Google Scholar 

  8. Mathiesen ER, Hommel E, Giese J, et al. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81–7

    Article  PubMed  CAS  Google Scholar 

  9. Viberti G, Mogensen CE, Groop LC, et al. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994; 271: 275–9

    CAS  Google Scholar 

  10. Ravid M, Savin H, Jutrin I, et al. Long-term stabilizing effect of angiotensin-converting-enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577–81

    PubMed  CAS  Google Scholar 

  11. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346: 1080–4

    Article  PubMed  CAS  Google Scholar 

  12. Bennett PH, Haffner S, Kasiske BL, et al. Diabetic disease recommendations. Screening and management of microalbuminuria in patients with diabetes: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107–12

    CAS  Google Scholar 

  13. Gilbert RE, Jasik M, Deluise M, et al. Position statement: diabetes and hypertension. Med J Aust 1995; 163: 372–5

    PubMed  CAS  Google Scholar 

  14. Mimiran A, Insua A, Ribstein J, et al. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 1988; 11: 850–3

    Article  Google Scholar 

  15. Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987–8

    PubMed  CAS  Google Scholar 

  16. Borch-Johnsen K. ACE inhibitors in patients with diabetes mellitus: clinical and economic considerations. PharmacoEconomics 1996 May; 9(5): 392–8

    Article  PubMed  CAS  Google Scholar 

  17. Szucs T, Ritz E, Standl E. Die Wirtschaftlichkeit von Captopril. Munch Med Wschr 1994; 136: 581–5

    Google Scholar 

  18. Siegel JE, Krolewski AS, Warram JH, et al. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 1992; 3: 311–9

    Google Scholar 

  19. Borch-Johnsen K, Wenzel H, Viberti GC, et al. Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes? BMJ 1993; 306: 1722–5

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Use ACE inhibitors for persistent microalbuminuria in diabetes. Drugs Ther. Perspect 7, 10–13 (1996). https://doi.org/10.2165/00042310-199607110-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607110-00004

Search

Navigation